{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:27:00Z","timestamp":1791901620141,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T00:00:00Z","timestamp":1395360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T00:00:00Z","timestamp":1395360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Although neuropsychiatric systemic lupus erythematosus (NPSLE) is one of the recalcitrant complications of the disease, its pathogenesis still remains unclear. Previous studies revealed that antibodies reactive with NMDA (N-methyl-D-aspartate) receptor NR2 (anti-NR2) are elevated in cerebrospinal fluid (CSF) of patients with diffuse psychiatric\/neuropsychological syndromes (diffuse NPSLE), which is usually more recalcitrant than neurologic syndromes of NPSLE (focal NPSLE). Two mechanisms have been implicated for the elevation of CSF IgG, including intrathecal synthesis and transudation through the damaged blood-brain barrier (BBB). The present study was designed in order to elucidate the roles of BBB function and intrathecal synthesis of anti-NR2 in the elevation of CSF anti-NR2 with regard to the severity in NPSLE.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Paired serum and CSF samples were obtained from 81 systemic lupus erythematosus (SLE) patients when they presented active neuropsychiatric manifestations, and from 22 non-SLE control patients with non-inflammatory neurological diseases. The 81 SLE patients consisted of 55 patients with diffuse NPSLE, including 23 patients with acute confusional state (ACS), the severest form of diffuse NPSLE, and 26 patients with neurologic syndromes or peripheral nervous system involvement (focal NPSLE). IgG anti-NR2 and albumin were measured by ELISA. BBB function and intrathecal synthesis of anti-NR2 were evaluated by Q albumin and by CSF anti-NR2 index, respectively.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>CSF anti-NR2 levels, Q albumin and CSF anti-NR2 index were significantly higher in NPSLE than in non-SLE control. CSF anti-NR2 levels and Q albumin were significantly higher in ACS than in non-ACS diffuse NPSLE (anxiety disorder, cognitive dysfunction, mood disorder and psychosis) or in focal NPSLE, whereas there was no significant difference in CSF anti-NR2 index among the 3 groups. CSF anti-NR2 levels were significantly correlated with Q albumin in diffuse NPSLE (r\u2009=\u20090.3754, <jats:italic>P<\/jats:italic>\u2009=\u20090.0053).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>These results demonstrate that the severity of BBB damages plays a crucial role in the development of ACS, the severest form of diffuse NPSLE, through the accelerated entry of larger amounts of anti-NR2 into the central nervous system.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar4518","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T18:03:13Z","timestamp":1395424993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematosus"],"prefix":"10.1186","volume":"16","author":[{"given":"Shunsei","family":"Hirohata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Arinuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamiko","family":"Yanagida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Yoshio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,21]]},"reference":[{"key":"4263_CR1","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/ard.35.5.398","volume":"35","author":"T Gibson","year":"1975","unstructured":"Gibson T, Myers AR: Nervous system involvement in systemic lupus erythematosus. Ann Rheum Dis. 1975, 35: 398-406.","journal-title":"Ann Rheum Dis"},{"key":"4263_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF00197299","volume":"8","author":"EN Harris","year":"1985","unstructured":"Harris EN, Hughes GR: Cerebral disease in systemic lupus erythematosus. Springer Semin Immunopathol. 1985, 8: 251-266.","journal-title":"Springer Semin Immunopathol"},{"key":"4263_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","volume":"42","author":"ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature","year":"1999","unstructured":"ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature: The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999, 42: 599-608.","journal-title":"Arthritis Rheum"},{"key":"4263_CR4","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1136\/ard.2010.130476","volume":"69","author":"GK Bertsias","year":"2010","unstructured":"Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M, Doria A, Hanly JG, Huizinga TW, Isenberg D, Kallenberg C, Piette JC, Schneider M, Scolding N, Smolen J, Stara A, Tassiulas I, Tektonidou M, Tincani A, van Buchem MA, van Vollenhoven R, Ward M, Gordon C, Boumpas DT: EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010, 69: 2074-2082. 10.1136\/ard.2010.130476.","journal-title":"Ann Rheum Dis"},{"key":"4263_CR5","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/art.1780330506","volume":"33","author":"S Hirohata","year":"1990","unstructured":"Hirohata S, Miyamoto T: Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum. 1990, 33: 644-649. 10.1002\/art.1780330506.","journal-title":"Arthritis Rheum"},{"key":"4263_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/096120330000900704","volume":"9","author":"E Trysberg","year":"2000","unstructured":"Trysberg E, Carlsten H, Tarkowski A: Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus. 2000, 9: 498-503. 10.1177\/096120330000900704.","journal-title":"Lupus"},{"key":"4263_CR7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3109\/s10165-009-0198-5","volume":"19","author":"P Efthimiou","year":"2009","unstructured":"Efthimiou P, Blanco M: Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers. Mod Rheumatol. 2009, 19: 457-468. 10.3109\/s10165-009-0198-5.","journal-title":"Mod Rheumatol"},{"key":"4263_CR8","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/art.22451","volume":"56","author":"H Fragoso-Loyo","year":"2007","unstructured":"Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narv\u00e1ez A, D\u00e1vila-Maldonado L, Atisha-Fregoso Y, Llorente L, S\u00e1nchez-Guerrero J: Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum. 2007, 56: 1242-1250. 10.1002\/art.22451.","journal-title":"Arthritis Rheum"},{"key":"4263_CR9","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s10067-009-1226-8","volume":"28","author":"S Hirohata","year":"2009","unstructured":"Hirohata S, Kanai Y, Mitsuo A, Tokano Y, Hashimoto H, NPSLE Research Subcommittee: Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study. Clin Rheumatol. 2009, 28: 1319-1323. 10.1007\/s10067-009-1226-8.","journal-title":"Clin Rheumatol"},{"key":"4263_CR10","first-page":"34","volume":"101","author":"Y Horai","year":"2010","unstructured":"Horai Y, Watanabe H, Miyamura T, Takahama S, Hirata A, Nakamura M, Ando H, Minami R, Yamamoto M, Suematsu E: Clinical analysis of cerebrospinal fluid interleukin-6 in neuropsychiatric systemic lupus erythematosus. Fukuoka Igaku Zasshi. 2010, 101: 34-40.","journal-title":"Fukuoka Igaku Zasshi"},{"key":"4263_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0002-9343(81)90756-7","volume":"70","author":"HG Bluestein","year":"1981","unstructured":"Bluestein HG, Williams GW, Steinberg AD: Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med. 1981, 70: 240-246. 10.1016\/0002-9343(81)90756-7.","journal-title":"Am J Med"},{"key":"4263_CR12","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/1529-0131(199810)41:10<1819::AID-ART14>3.0.CO;2-Y","volume":"41","author":"K Isshi","year":"1998","unstructured":"Isshi K, Hirohata S: Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum. 1998, 41: 1819-1827. 10.1002\/1529-0131(199810)41:10<1819::AID-ART14>3.0.CO;2-Y.","journal-title":"Arthritis Rheum"},{"key":"4263_CR13","doi-asserted-by":"publisher","first-page":"R44","DOI":"10.1186\/ar2184","volume":"9","author":"S Hirohata","year":"2007","unstructured":"Hirohata S, Arinuma Y, Takayama M, Yoshio T: Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res Ther. 2007, 9: R44-10.1186\/ar2184.","journal-title":"Arthritis Res Ther"},{"key":"4263_CR14","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/art.23399","volume":"58","author":"Y Arinuma","year":"2008","unstructured":"Arinuma Y, Yanagida T, Hirohata S: Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2008, 58: 1130-1135. 10.1002\/art.23399.","journal-title":"Arthritis Rheum"},{"key":"4263_CR15","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/art.21547","volume":"54","author":"T Yoshio","year":"2006","unstructured":"Yoshio T, Onda K, Nara H, Minota S: Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2006, 54: 675-678. 10.1002\/art.21547.","journal-title":"Arthritis Rheum"},{"key":"4263_CR16","doi-asserted-by":"publisher","first-page":"e3347","DOI":"10.1371\/journal.pone.0003347","volume":"3","author":"H Fragoso-Loyo","year":"2008","unstructured":"Fragoso-Loyo H, Cabiedes J, Orozco-Narv\u00e1ez A, D\u00e1vila-Maldonado L, Atisha-Fregoso Y, Diamond B, Llorente L, S\u00e1nchez-Guerrero J: Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One. 2008, 3: e3347-10.1371\/journal.pone.0003347.","journal-title":"PLoS One"},{"key":"4263_CR17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3109\/00365517709091496","volume":"37","author":"G Tibbling","year":"1977","unstructured":"Tibbling G, Link H, Ohman S: Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest. 1977, 37: 385-390. 10.3109\/00365517709091496.","journal-title":"Scand J Clin Lab Invest"},{"key":"4263_CR18","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/0002-9343(83)91075-6","volume":"74","author":"JB Winfield","year":"1983","unstructured":"Winfield JB, Shaw M, Silverman LM, Eisenberg RA, Wilson HA, Koffler D: Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am J Med. 1983, 74: 837-844. 10.1016\/0002-9343(83)91075-6.","journal-title":"Am J Med"},{"key":"4263_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","volume":"184","author":"H Reiber","year":"2001","unstructured":"Reiber H, Peter JB: Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001, 184: 101-122. 10.1016\/S0022-510X(00)00501-3.","journal-title":"J Neurol Sci"},{"key":"4263_CR20","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1001\/archinte.1985.00360100105017","volume":"145","author":"S Hirohata","year":"1985","unstructured":"Hirohata S, Hirose S, Miyamoto T: Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity. Arch Intern Med. 1985, 145: 1843-1846. 10.1001\/archinte.1985.00360100105017.","journal-title":"Arch Intern Med"},{"key":"4263_CR21","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25: 1271-1277. 10.1002\/art.1780251101.","journal-title":"Arthritis Rheum"},{"key":"4263_CR22","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/nm1101-1189","volume":"7","author":"LA DeGiorgio","year":"2001","unstructured":"DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B: A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med. 2001, 7: 1189-1193. 10.1038\/nm1101-1189.","journal-title":"Nat Med"},{"key":"4263_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature04089","volume":"438","author":"H Furukawa","year":"2005","unstructured":"Furukawa H, Singh SK, Mancusso R, Gouaux E: Subunit arrangement and function in NMDA receptors. Nature. 2005, 438: 185-192. 10.1038\/nature04089.","journal-title":"Nature"},{"key":"4263_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1472-8206.1993.tb01036.x","volume":"7","author":"B Scatton","year":"1993","unstructured":"Scatton B: The NMDA receptor complex. Fundam Clin Pharmacol. 1993, 7: 389-400. 10.1111\/j.1472-8206.1993.tb01036.x.","journal-title":"Fundam Clin Pharmacol"},{"key":"4263_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","volume":"21","author":"C Kowal","year":"2004","unstructured":"Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, Volpe BT: Cognition and immunity; antibody impairs memory. Immunity. 2004, 21: 179-188. 10.1016\/j.immuni.2004.07.011.","journal-title":"Immunity"},{"key":"4263_CR26","doi-asserted-by":"publisher","first-page":"18569","DOI":"10.1073\/pnas.1006980107","volume":"107","author":"TW Faust","year":"2010","unstructured":"Faust TW, Chang EH, Kowal C, Berlin R, Gazaryan IG, Bertini E, Zhang J, Sanchez-Guerrero J, Fragoso-Loyo HE, Volpe BT, Diamond B, Huerta PT: Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc Natl Acad Sci USA. 2010, 107: 18569-18574. 10.1073\/pnas.1006980107.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4263_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/art.37745","volume":"65","author":"T Yoshio","year":"2013","unstructured":"Yoshio T, Okamoto H, Hirohata S, Minota S: IgG anti-NR2 glutamate receptor autoantibodies from patients with systemic lupus erythematosus activate endothelial cells. Arthritis Rheum. 2013, 65: 457-463. 10.1002\/art.37745.","journal-title":"Arthritis Rheum"},{"key":"4263_CR28","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1002\/1529-0131(199912)42:12<2729::AID-ANR35>3.0.CO;2-I","volume":"42","author":"S Hirohata","year":"1999","unstructured":"Hirohata S, Hayakawa K: Enhanced interleukin-6 messenger RNA expression by neuronal cells in a patient with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 1999, 42: 2729-2730. 10.1002\/1529-0131(199912)42:12<2729::AID-ANR35>3.0.CO;2-I.","journal-title":"Arthritis Rheum"},{"key":"4263_CR29","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/art.20869","volume":"52","author":"T Nagai","year":"2005","unstructured":"Nagai T, Arinuma Y, Yanagida T, Yamamoto K, Hirohata S: Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes. Arthritis Rheum. 2005, 52: 847-855. 10.1002\/art.20869.","journal-title":"Arthritis Rheum"},{"key":"4263_CR30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10157-011-0462-9","volume":"15","author":"S Hirohata","year":"2011","unstructured":"Hirohata S: Anti-ribosomal P antibodies and lupus nephritis. Clin Exp Nephrol. 2011, 15: 471-477. 10.1007\/s10157-011-0462-9.","journal-title":"Clin Exp Nephrol"},{"key":"4263_CR31","doi-asserted-by":"publisher","first-page":"C740","DOI":"10.1152\/ajpcell.00516.2005","volume":"291","author":"L Krizanac-Bengez","year":"2006","unstructured":"Krizanac-Bengez L, Hossain M, Fazio V, Mayberg M, Janigro D: Loss of flow induces leukocyte-mediated MMP\/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines. Am J Physiol Cell Physiol. 2006, 291: C740-C749. 10.1152\/ajpcell.00516.2005.","journal-title":"Am J Physiol Cell Physiol"},{"key":"4263_CR32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.brainres.2012.06.054","volume":"1471","author":"T Barichello","year":"2012","unstructured":"Barichello T, Fagundes GD, Generoso JS, Paula Moreira A, Costa CS, Zanatta JR: Brain-blood barrier breakdown and pro-inflammatory mediators in neonate rats submitted meningitis by Streptococcus pneumoniae. Brain Res. 2012, 1471: 162-168.","journal-title":"Brain Res"},{"key":"4263_CR33","first-page":"31","volume":"46","author":"T Iwasaki","year":"1999","unstructured":"Iwasaki T, Kanda T, Mizusawa H: Effects of pericytes and various cytokines on integrity of endothelial monolayer originated from blood-nerve barrier: an in vitro study. J Med Dent Sci. 1999, 46: 31-40.","journal-title":"J Med Dent Sci"},{"key":"4263_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.brainres.2004.07.033","volume":"1023","author":"NY Lee","year":"2004","unstructured":"Lee NY, Kang YS: The brain-to-blood efflux transport of taurine and changes in the blood-brain barrier transport system by tumor necrosis factor-alpha. Brain Res. 2004, 1023: 141-147. 10.1016\/j.brainres.2004.07.033.","journal-title":"Brain Res"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4518.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar4518\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4518.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:15:25Z","timestamp":1728382525000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar4518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,21]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,4]]}},"alternative-id":["4263"],"URL":"https:\/\/doi.org\/10.1186\/ar4518","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,21]]},"assertion":[{"value":"24 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R77"}}